NIH-funded research R01 grant

Improve brain tumor radiation planning with high-resolution MR spectroscopy

Official title: Improving Image-Guided Radiation Therapy of Gliomas with High-Resolution MR Spectroscopic Imaging

Funded at Yale University · NIH-11360705 · Data updated 2026-11-12

Aims to use advanced MR spectroscopy imaging to more precisely target glioma tumors during radiation therapy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 30, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$464,213
NIH project number5R01EB033582-05
Project IDNIH-11360705 on NIH RePORTER

Who could benefit from this research

Could help

Patients with newly diagnosed glioma undergoing radiation therapy.

Less likely to help

Patients not eligible for MR spectroscopy-guided planning or without glioma may not benefit.

What this research studies

This project at Yale University explores how high-resolution MR spectroscopic imaging can improve delineation of glioma boundaries to guide radiation therapy. By combining metabolic information from MRSI with standard MRI, clinicians may better define tumor edges and reduce damage to healthy brain tissue. The study builds on prior phase I results showing promise for dose-escalation strategies guided by metabolic imaging. Researchers will develop imaging protocols, correlate imaging findings with pathological data, and evaluate how these insights could refine treatment planning. The goal is to translate improved imaging accuracy into more effective and safer radiation treatment for glioma patients.

Why it matters

Potential benefit: If successful, patients could receive more precisely targeted radiation, potentially improving tumor control and reducing side effects.

How similar studies have gone: Previous early-phase work suggests that MRSI-guided planning can improve targeting, but larger validation is needed.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Ma, Chao — Yale University
  • Study coordinator: Ma, Chao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.